We are live on ! Find out more
AC

AKO Capital Portfolio holdings

AUM $5.11B
1-Year Est. Return 2.56%
This Fund
S&P 500
This Quarter Est. Return
+9.49%
1 Year Est. Return
-2.56%
3 Year Est. Return
+42.63%
5 Year Est. Return
+64.88%
10 Year Est. Return
–
AUM
$6.37B
AUM Growth
+$645M
Cap. Flow
+$169M
Cap. Flow %
2.65%
Top 10 Hldgs %
60.7%
Holding
27
New
3
Increased
15
Reduced
7
Closed
2

Top Buys

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$180M
2
ICE icon
Intercontinental Exchange
ICE
+$145M
3
UAA icon
Under Armour
UAA
+$106M
4
NKE icon
Nike
NKE
+$62.3M
5
ALLE icon
Allegion
ALLE
+$46.9M

Top Sells

Rank Stock Value
1
GRFS
Grifois
GRFS
+$224M
2
LIN icon
Linde
LIN
+$105M
3
CME icon
CME Group
CME
+$104M
4
OTIS icon
Otis Worldwide
OTIS
+$49.7M
5
ANSS
Ansys
ANSS
+$23.4M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 25.04%
2 Materials 13.8%
3 Technology 12.65%
4 Consumer Staples 12%
5 Financials 11.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CME icon
26
CME Group
CME
$93.5B
– –
-638,179
Closed -$104M
GRFS
27
Grifois
GRFS
$5.44B
– –
-12,273,278
Closed -$224M
1
2

Similar funds

CIA
Choate Investment Advisors Boston, Massachusetts $5.11B AUM 17.2% 1-Year Est. Return
EIC
Equity Investment Corp Atlanta, Georgia $5.11B AUM 8.63% 1-Year Est. Return
TAM
Todd Asset Management Louisville, Kentucky $5.11B AUM 34.73% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
CS
Cannell & Spears New York $5.1B AUM 31.77% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
NC
Nicholas Company Milwaukee, Wisconsin $5.1B AUM 8.43% 1-Year Est. Return
VT
Vise Technologies New York $5.09B AUM 22.62% 1-Year Est. Return

AKO Capital's Q3 2020 Portfolio in Review

As of Q3 2020, AKO Capital held 27 positions worth $6.37B, up 11% from $5.73B the previous quarter. Its ten largest holdings account for 61% of the portfolio.

AKO Capital's Q3 2020 filing shows 3 new, 15 increased, 7 reduced and 2 closed positions. Its largest new stake was Thermo Fisher Scientific: 435,377 shares worth $192M. The largest sale was Grifois, an estimated $224M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 25% of assets, up from 22% a quarter earlier, followed by Materials and Technology.

  • AKO Capital's largest Q3 2020 buy was Thermo Fisher Scientific: 435,377 shares worth $192M.
  • AKO Capital added most to Nike in Q3 2020, an estimated $62.3M increase.
  • AKO Capital's biggest Q3 2020 reduction was Linde, cutting an estimated $105M.
  • AKO Capital fully exited Grifois in Q3 2020, selling an estimated $224M.
  • AKO Capital's ten largest holdings make up 61% of its $6.37B portfolio in Q3 2020.
  • AKO Capital opened 3 new positions and closed 2 in Q3 2020.
  • AKO Capital's portfolio value rose 11% quarter-over-quarter to $6.37B.

Based on AKO Capital's 13F filing for Q3 2020, filed 2 Nov 2020.